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Abstract
Background: The control of the functional pancreatic b-cell mass serves the key homeostatic function of releasing the right
amount of insulin to keep blood sugar in the normal range. It is not fully understood though how b-cell mass is determined.
Methodology/Principal Findings: Conditional chicken ovalbumin upstream promoter transcription factor II (COUP-TFII)-
deficient mice were generated and crossed with mice expressing Cre under the control of pancreatic duodenal homeobox 1
(pdx1) gene promoter. Ablation of COUP-TFII in pancreas resulted in glucose intolerance. Beta-cell number was reduced at 1
day and 3 weeks postnatal. Together with a reduced number of insulin-containing cells in the ductal epithelium and normal
b-cell proliferation and apoptosis, this suggests decreased b-cell differentiation in the neonatal period. By testing islets
isolated from these mice and cultured b-cells with loss and gain of COUP-TFII function, we found that COUP-TFII induces the
expression of the b-catenin gene and its target genes such as cyclin D1 and axin 2. Moreover, induction of these genes by
glucagon-like peptide 1 (GLP-1) via b-catenin was impaired in absence of COUP-TFII. The expression of two other target
genes of GLP-1 signaling, GLP-1R and PDX-1 was significantly lower in mutant islets compared to control islets, possibly
contributing to reduced b-cell mass. Finally, we demonstrated that COUP-TFII expression was activated by the Wnt
signaling-associated transcription factor TCF7L2 (T-cell factor 7-like 2) in human islets and rat b-cells providing a feedback
loop.
Conclusions/Significance: Our findings show that COUP-TFII is a novel component of the GLP-1 signaling cascade that
increases b-cell number during the neonatal period. COUP-TFII is required for GLP-1 activation of the b-catenin-dependent
pathway and its expression is under the control of TCF7L2.
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Introduction
Type 2 diabetes mellitus (T2DM) is a multifactorial disorder
associated with impaired pancreatic b-cell function and insulin
resistance. The onset of b-cell dysfunction in T2DM is complex,
involving genetic and environmental factors that lead to decreased
insulin secretion and reduced b-cell mass [1]. The identification of
pathways that regulate b-cell function and mass in concert may
lead to the development of novel therapeutic strategies for the
treatment of T2DM and related disorders.
Chicken Ovalbumin Upstream Promoter Transcription Factor
II (COUP-TFII, formerly known as NR2F2) belongs to the
subfamily of nuclear hormone receptors that includes hepatocyte
nuclear factor (HNF) 4a/maturity onset diabetes of the young
(MODY)1 and the retinoid X receptor [2]. COUP-TFII acts in
genetic programs associated with insulin biosynthesis and secretion
in pancreatic b-cells, and in the regulation of lipid/energy
metabolism and white adipose tissue development. Our original
finding that COUP-TFII is highly expressed in islet b-cells [3,4]
led us to focus on the role of the COUP-TFII on pancreatic b-cell
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COUP-TFII knockout mouse model and ex vivo and in vitro
experiments, we reported that a decrease in COUP-TFII
expression in b-cells is associated with defects in insulin production
and secretion but b-cell mass is unaffected [3,5]. Knockout mice
with heterozygous deletion of COUP-TFII and mice with
complete disruption of HNF4a in pancreatic b-cells have similar
defects in insulin secretion, which led us to propose a model of
transcriptional crosstalk between these two nuclear receptors. We
then established that COUP-TFII contributes to the control of
insulin secretion through the complex HNF4a/MODY1 tran-
scription factor network operating in b-cells [4].
The well-characterized canonical Wnt/b-catenin pathway is
critical for the development, renewal and function of various
tissues. In the absence of Wnt, cytoplasmic b-catenin is unstable
due to its phosphorylation and is degraded. Upon binding of Wnt
to Frizzled receptor, which prevents b-catenin phosphorylation,
the canonical pathway is activated. The unphosphorylated form of
b-catenin accumulates in the cytoplasm, resulting in its stabiliza-
tion and translocation into the nucleus. Once inside the nucleus, b-
catenin, acting with transcription factors such as T-cell factor 7-
like 2 (TCF7L2), stimulates transcription of various Wnt target
genes, including cyclin D, c-myc and axin 2 [6,7].
Recently, several gene loci that encode proteins that are either
components of, or known target genes for the b-catenin/TCF7L2-
dependent Wnt signaling pathway, have been discovered to confer
susceptibility to the development of T2DM in human genetic
studies. For example, at-risk alleles of TCF7L2 are associated with
diabetic phenotypes characterized by impaired b-cell function and
a reduction in GLP-1-induced potentiation of insulin secretion
[8,9,10,11]. The role of the canonical Wnt/b-catenin pathway in
pancreatic b-cells is somewhat complex, because it differs
depending on the age of the animal [12,13,14,15] and crosstalk
with other signaling pathways [16,11]. The gluco-incretin
hormone glucagon-like peptide 1 (GLP-1) or the long-acting
agonist of the GLP-1 receptor (GLP-1R), exendin-4 (Exd4),
activate b-catenin/TCF7L2 signaling to induce cyclin D1 and cell
proliferation [17]. GLP-1 can also prevent apoptosis [18,19,20]
and restore functional pancreatic b-cell mass in rodent models
[21,22,23,24].
Here, we report that COUP-TFII is a novel component of the
GLP-1 signaling cascade that increases b-cell number during the
neonatal period.
Results
Pdx1
CRE/- COUP-TFII
Fl/Fl mice are glucose intolerant
Since the nuclear receptor COUP-TFII is highly expressed in
pancreatic b-cells, we generated mice to study the consequences of
total b-cell ablation of COUP-TFII gene expression on b-cell
function and glucose homeostasis using the Cre recombinase/loxP
system. The pancreatic duodenal homeobox 1 (pdx1)
CRE
transgenic mouse line used in this study has a robust and early
Cre recombinase activity in pancreas progenitors, in exocrine
(acinar and ductal) cells and endocrine cells during development
and after birth is active only in pancreatic b-cells [25]. Pdx1
CRE/-
COUP-TFII
Fl/Fl mutant mice were generated by mating COUP-
TFII
Fl/wt with pdx1
CRE/- COUP-TFII
Fl/wt and their phenotypes
were compared with controls pdx1
CRE/- and COUP-TFII
Fl/Fl.A s
previously reported, immunostaining with COUP-TFII antibodies
showed COUP-TFII protein present in pancreatic b-cells of con-
trol COUP-TFII
Fl/Fl or pdx1
CRE/- mice [4], but not in pancreatic
b-cells of pdx1
CRE/- COUP-TFII
Fl/Fl mice (Fig. 1A). We did not
detect COUP-TFII expression in mouse enteroendocrine cells in
the duodenum where pdx1 expression had been reported [26] (data
not shown).
Both male and female pdx1
CRE/- COUP-TFII
Fl/Fl mice had
very low fasting serum insulin levels compared to control
littermates at four months of age (Fig. 1B, left panel). This fasting
hypoinsulinemia was already detected in six-week-old mice (Fig. 1B
right panel). When glucose was administered in a glucose tolerance
test, all three groups of adult male mice showed very similar blood
glucose levels after 20 minutes (Fig. 1C left panel). From 60
minutes onwards, pdx1
CRE/- COUP-TFII
Fl/Fl mice had higher
blood glucose levels than pdx1
CRE/- and COUP-TFII
Fl/Fl control
littermates (Fig. 1C left panel). In addition, the glucose dis-
appearance rate (K) in pdx1
CRE/- COUP-TFII
Fl/Fl mice was
almost half of that in control littermates (Fig. 1C), confirming that
mutant mice were glucose intolerant. Insulin levels were sig-
nificantly lower in pdx1
CRE/- COUP-TFII
Fl/Fl mice than in
controls at all corresponding time points, additional evidence that
the knockout mice have a defect in insulin secretion in response to
glucose (Fig. 1C right panel). Similar results were obtained with
female mice (data not shown). The combination of glucose
intolerance and inappropriate low insulin levels during the glucose
tolerance test led us to further examine the functional b-cell mass
in pdx1
CRE/- COUP-TFII
Fl/Fl mice.
Pdx1
CRE/- COUP-TFII
Fl/Fl mice have reduced pancreatic b-
cell mass at the neonatal stage
Whole pancreases from adult pdx1
CRE/- COUP-TFII
Fl/Fl
mice weighed 281 6 5.5 mg, similar to pancreases from COUP-
TFII
Fl/Fl weighing 291 6 12 mg and from pdx1
CRE/- weighing
271.5 6 1.5 mg. Islets from adult mice were immunostained for
insulin, indicative of b-cells, and for glucagon, indicative of a-
cells. Islets from adult pdx1
CRE/- COUP-TFII
Fl/Fl mice had a
typical tissue arrangement where the majority of cells, insulin-
positive b-cells, were surrounded by fewer glucagon-positive a-
cells at the periphery (Fig. 2A). There were fewer b-cells in the
islet core in pdx1
CRE/- COUP-TFII
Fl/Fl mice than in control
mice. Quantitative analysis of the cellular composition of
pancreatic sections showed that the fraction of b-cells was 50%
smaller in pdx1
CRE/- COUP-TFII
Fl/Fl (Fig. 2B) indicating a
decrease in b-cell mass (Fig. 2B). In contrast, a-cell fraction and
a-cell mass in pdx1
CRE/- COUP-TFII
Fl/Fl animals were similar
to those found in control groups (Figure S1A). An overall
decrease in b-cell mass could result either from smaller b-cells
(hypotrophy) or fewer b-cells (hypoplasia). To estimate b-cell size,
we measured the cross-sectional area of individual b-cells in
pancreas sections. The average cross-sectional area of individual
b-cells in pdx1
CRE/- COUP-TFII
Fl/Fl mice was not different
from controls supporting the notion that the decrease in the total
b-cell mass is probably due to b-cell hypoplasia (Fig. 2B). A
similar decrease of 50% in b-cell number was measured in
pdx1
CRE/- COUP-TFII
Fl/Fl mice at 3 weeks of age (Fig. 2C). At
postnatal day 1(P1), we observed b-cell hypoplasia with a 23%
reduction in b-cells compared to littermate controls (Fig. 2D).
Since Pdx1-Cre is expressed in the pancreatic epithelium during
embryogenesis [25] and COUP-TFII expression can be detected
in insulin-positive embryonic cells [27], we counted the endocrine
cells present at E12.5 and E14.5. The total numbers of glucagon-
and insulin-expressing cells were similar in mutant mice and in
control littermates at both stages (Figure S1B and Figure S1C).
Therefore, lower insulin secretion and impaired regulation of
glucose homeostasis in pdx1
CRE/- COUP-TFII
Fl/Fl mice is most
likely the result of a decrease in b-cell number that occurs at the
end of gestation and around birth.
COUP-TFII, a Regulator of b-Cell Number
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CRE/- COUP-TFII
Fl/Fl mice have defective glucose homeostasis. (A) Immunostaining of pancreatic sections from COUP-TFII
Fl/Fl
control and pdx1
CRE/- COUP-TFII
Fl/Fl adult mice using mouse monoclonal antibodies against COUP-TFII. Scale bars= 100 mm (B) Fasting plasma insulin
of 4 month and 6- week-old mice littermates. (C) Intraperitoneal glucose tolerance tests were performed in 4-month-old male pdx1
CRE/-, COUP-TFII
Fl/Fl
and pdx1
CRE/- COUP-TFII
Fl/Fl mice that had been fasted for 14 h. Blood glucose levels, left panel. Rate of glucose disappearance (K), inset panel. Plasma
insulin levels, right panel. Results are mean 6 SEM (error bars) for 8 to 14 animals per genotype. Values for pdx1
CRE/- COUP-TFII
Fl/Fl are significantly
different from values for COUP-TFII
Fl/Fl and pdx1
CRE/- control mice at P,0.05 (*) or P,0.03 (**).
doi:10.1371/journal.pone.0030847.g001
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PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30847Figure 2. Pdx1
CRE/- COUP-TFII
Fl/Fl mice have fewer b-cells at birth. (A) Pancreatic sections from adult mice were immunostained for pancreatic
b-cells and a-cells using respectively anti-insulin and anti-glucagon antibodies. Scale bars= 100 mm (B) Estimation of the relative b-cell area and b-cell
mass in the pancreatic sections of pdx1
CRE/-, COUP-TFII
Fl/Fl and pdx1
CRE/-COUP-TFII
Fl/Fl in 4-month-old mice. Beta-cell mass was estimated by
morphometric analysis. Relative b-cell size (mean of $ 1500 cells counted). (C) Estimation of b-cell number and b-cell mass in pancreatic sections of 3-
week-old mice. (D) Ratio of Insulin-positive cross-sectional area relative to pancreas (DAPI-positive) cross-sectional area in one-day-old neonate
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differentiation
Beta-cell mass is increased by b-cell proliferation, b-cell
hypertrophy (increased cell size), and b-cell neogenesis (differen-
tiation from duct cells) and is decreased by b-cell death primarily
through apoptosis [28]. We sought to determine which mecha-
nisms in vivo and in vitro led to the observed decrease in b-cell mass.
In vivo, we evaluated the proliferating b-cells by double staining of
pancreatic sections for insulin and the G1, S, G2 and M marker
Ki67 (Fig. 3A). We found that COUP-TFII ablation did not alter
b-cell proliferation in the pancreas in 5-day-old (P5) pdx1
CRE/-
COUP-TFII
Fl/Fl mice compared to the COUP-TFII
Fl/Fl control
mice. We then looked at apoptotic cells within these pancreases. In
all groups, the frequency of b-cell apoptosis was extremely low and
we were unable to detect any differences between genotypes at this
stage (data not shown). Through lineage tracing experiments it has
recently been shown that b-cell neogenesis from ducts still occurs
at P1 [29,30]. We next evaluated an intermediate step of b-cell
differentiation by measuring the number of small clusters of insulin
containing cells within the ductal epithelium at P5. Cluster
number was significantly lower in the pancreas of pdx1
CRE/-
COUP-TFII
Fl/Fl compared to control (Fig. 3B). These results
together with the reduced number of b-cells at P1 and further
reduction at 3 weeks suggest a decrease in neogenesis at the end of
gestation and during the neonatal period.
We next examined the effect of COUP-TFII knockdown on the
viability of 832/13 INS-1 b-cells in culture. As already reported
[4], electroporation of a specific-COUP-TFII siRNA into 832/13
INS-1 cells causes a 80% decrease in COUP-TFII levels (Fig. 3C).
Cell viability was determined here by two approaches. Firstly, in
the colorimetric MTT assay, there were fewer living cells at 24 h
and significantly fewer at 48 h in COUP-TFII siRNA-transfected
832/13 INS-1 cells compared to scrambled siRNA-transfected
control cells (Fig. 3D). Secondly, we used flow cytometry FACS
analysis to examine the effect of COUP-TFII on cell number,
proliferation and apoptosis. Staining with BrdU revealed that both
cell populations underwent normal cell cycle progression confirm-
ing our in vivo observations. However, a sub G0/G1 peak, a
hallmark of apoptotic cells, was detected in the COUP-TFII
siRNA-transfected 832/13 INS-1 cell populations but not in
scrambled siRNA-transfected control populations (Fig. 3E). Since
a drop in mitochondrial membrane potential (Dym) is one of the
first events in early apoptosis [31], we measured Dymi n
transfected cells. As shown in figure 3F, the number of cells with
a large Dym doubled in the COUP-TFII knockdown cell
population indicating a 2-fold increase in apoptotic rate compared
to the control cell population. This degree of apoptosis induction is
comparable to the effect of high concentrations of cytokines,
known inducers of b-cell apoptosis [20], used here as a positive
control that induced a 4-fold increase in apoptosis. Altogether, in
vitro, these results suggest that COUP-TFII maintains b-cell
survival.
COUP-TFII induces expression of b-catenin and its target
genes in pancreatic b-cells
To understand the molecular mechanisms by which COUP-
TFII controls b-cell mass, we determined the RNA profile of
COUP-TFII knockdown b-cells using Affymetrix oligonucleotide
microarrays. This microarray expression analysis identified 464
significantly up-regulated and 505 significantly down-regulated
genes in COUP-TFII knockdown b-cells (GEO). Computational
analysis identified clusters of genes shared by different gene
regulatory networks (Figure S2 and Figure S3) namely genes
involved in Wnt/b-catenin signaling, insulin signaling and lipid/
carbohydrate metabolism. Cyclin D1 is a well-characterized
direct target gene of b-catenin/TCF7L2-dependent Wnt signal-
ing in b-cells [17]. COUP-TFII coordinates cell patterning
through modulation of Wnt signaling in other systems [32,33].
Therefore, we examined whether knockdown of COUP-TFII in
832/13 INS-1 cells modulates b-catenin/TCF7L2-dependent
Wnt targets. Our microarray analysis showed that levels of the
cyclin D1 (Ccnd1) transcripts were lower in COUP-TFII
depleted cells than in control cells (GEO database, accession
number: GSE30526). As shown in figure 4A, independent RT-
qPCR experiments indicated that cyclin D1 mRNA levels were
lowered by 55% in COUP-TFII depleted cells. Immunoblot
analysis indicated that cyclin D1 protein levels also fell coinciding
with observed changes in mRNA levels (Fig. 4B). However,
protein levels of the cyclin D-dependent kinase 4 (cdk-4), a kinase
associated with cyclin D1 in controlling G1 phase of the cell
cycle, were not modified in COUP-TFII knockdown b-cells
(Fig. 4B). Messenger RNA levels of Wnt target genes c-myc,
glutamine synthase and axin 2 all significantly decreased in
COUP-TFII depleted 832/13 INS-1 cells compared to control
cells (Fig. 4A) whereas cyclin D2 mRNA levels were not affected
(data not shown). We also examined whether COUP-TFII, being
a transcription factor, could control the expression of b-catenin
itself under the same experimental conditions. Indeed, knock-
down of COUP-TFII caused a significant 36% decrease in b-
catenin mRNA levels (Fig. 4A). To further address the
relationships between COUP-TFII and b-catenin/TCF7L2-
dependent Wnt signaling, we transfected COUP-TFII depleted
832/13 INS-1 cells with the TOP/FOPflash luciferase vectors, a
TCF/b-catenin-directed transcription system in which activity of
the luciferase reporter indicates activation of signaling via b-
catenin. TCF/b-catenin-dependent luciferase activity decreased
significantly by 25% in the absence of COUP-TFII (Fig. 4A). In
contrast, adenovirus-mediated overexpression of human COUP-
TFII in 832/13 INS-1 cells induced both b-catenin and cyclin D1
mRNA levels (Fig. 4C).
We next examined the Wnt signalling pathways in islets isolated
from 5-week-old mutant pdx1
CRE/- COUP-TFII
Fl/Fl mice.
Messager RNA levels of b-catenin, cyclin D1 and axin 2 were
markedly lower than in control islets (Fig. 4D). We also examined
the expression of pdx1, a master regulator of functional pancreatic
b-cell mass, and one of its target genes, proinsulin I-II. We found
that mRNA levels of both of these genes were significantly
decreased in COUP-TFII-ablated islets of pdx1
CRE/- COUP-
TFII
Fl/Fl mice compared to those from control littermates
(Fig. 4D). This reduction of pdx1- expression is probably a
consequence of the absence of COUP-TFII, not of direct control
[5]. Collectively, these results indicate that there is crosstalk
between COUP-TFII and the Wnt signaling pathway which may
promote pancreatic b-cell differentiation.
animals. # The reduction of pdx1
CRE/-, COUP-TFII
Fl/Fl over the cumulated controls (pdx1
CRE/- and COUP-TFII
Fl/Fl) is already quite important (23%) and is
significant with student t-test and non-parametric tests (2-tailed Mann-Whitney U test, which does not assume normal distribution: p=0.0476). It is
not significant if referred individually to the two control populations. Data are means 6 SEM (error bars) of values from 4 animals of each genotype.
*Values for pdx1
CRE/-, COUP-TFII
Fl/Fl mice is significantly different from the corresponding values for control mice (pdx1
CRE/- and COUP-TFII
Fl/Fl)a t
P,0.05.
doi:10.1371/journal.pone.0030847.g002
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b-catenin/TCF7L2 axes and its target gene cyclin D1
The transcription of cyclin D1 is induced by exendin-4 (Exd4), a
stable agonist of the glucagon-like peptide-1 receptor (GLP-1R),
via TCF7L2 and b-catenin in INS-1 cells [17]. This prompted us
to test whether COUP-TFII has a role in this process. We first
verified that GLP-1 signaling occurs by measuring expression of
insulin growth factor-1 receptor (IGF-1R), a known target gene of
gluco-incretin hormone signaling [20] in 832/13 INS-1 cells.
GLP-1 or Exd4 induced IGF-1R mRNA expression in cells within
6 h (Fig. 5A). Treatment with GLP-1 or Exd4 also induced cyclin
D1 mRNA levels (Figure 5B lane 1 vs. lanes 2 and 3) in b-cells
culture. As expected and as shown in figure 4A, transfection with
COUP-TFII siRNA caused a decrease in basal cyclin D1 mRNA
levels (Fig. 5B lane 1 vs. lane 4). In addition, COUP-TFII
knockdown almost halved Exd4 induced increase in cyclin D1
mRNA (Fig. 5B lanes 1 and 3 vs. lanes 4 and 5). We then
examined whether b-catenin is required for Exd4-mediated cyclin
D1 induction, as might be expected, in wild type (Figure S4) and
COUP-TFII depleted cells. This was done by adenovirus-
mediated overexpression of b-catenin. In the absence of COUP-
TFII, a 3.7 fold increase in cyclin D1 mRNA levels was restored
when b-catenin was overexpressed (Figure 5B, lanes 4 and 6).
These results demonstrate the requirement of COUP-TFII in the
induction of cyclin D1 by GLP-1 via increased b-catenin levels.
Since GLP-1 is known to activate Wnt signaling in cultured b-
cells via the GLP-1R [17], we compared the expression of some
Wnt target genes in islets isolated from mice in which incretin
receptors were inactivated. As previously reported [20], we found
significantly lower IGF-1R mRNA levels in islets isolated from
these GipR
-/-; Glp-1R
-/- mice compared to control littermates. We
also detected a marked decrease in cyclin D1 mRNA and axin 2
mRNA levels (Fig. 5C).
Altogether, these ex vivo and in vivo results indicate that full
activation of the b-catenin/TCF7L2-dependent Wnt signaling
pathway by GLP-1 via GLP-1R requires COUP-TFII expression
in pancreatic b-cells.
Absence of COUP-TFII in islets results in decreased GLP-1
receptor expression
While the fold induction of cyclin D1 expression in response to
exendin-4 recovers in COUP-TFII depleted 832/13 INS-1-cells
when b-catenin is overexpressed, the absolute amount of cyclin D1
mRNA does not reach that of the control (Fig. 5B). It is likely that
other components of the GLP-1 signaling pathway altered in the
absence of COUP-TFII also contribute to the observed pheno-
type. We analyzed whether IGF-1R [20] and GLP-1R [34], two
target genes of the GLP-1 signaling cascades, but not known to be
b2catenin dependent targets, may be altered in islets isolated from
5-week-old mutant pdx1
CRE/- COUP-TFII
Fl/Fl mice. We did not
detect any changes in IGF-1R mRNA levels but a significant
reduction of GLP-1R mRNA levels were measured in islets
isolated from 5-week-old mutant pdx1
CRE/- COUP-TFII
Fl/Fl
mice compared to those from control littermates (Fig. 6).
COUP-TFII expression is activated by TCF7L2 in b-cells
Since there is a direct interplay between GLP-1R/GIP-R and
TCF7L2 in human islets [34], we examined COUP-TFII protein
expression in isolated human pancreatic islets exposed to siRNA
directed to TCF7L2 or scrambled control siRNA and cultured as
previously described [34]. Triple staining for COUP-TFII, insulin
and DAPI revealed that COUP-TFII was almost undetectable in
TCF7L2 depleted b-cells (Fig. 7A). Also down-regulation of
TCF7L2 by TCF7L2 siRNA in rat 832/13 INS-1 resulted in
down-regulation of COUP-TFII mRNA abundance and conse-
quently decreased cyclin D1 expression when compared to
scrambled siRNA. This control may represent a feedforward loop
by which both COUP-TFII and TCF7L2 positively regulate each
other.
Discussion
The development and maintenance of pancreatic b-cell mass
and function are important determinants of an organism’s
homeostatic capacity to respond to changing blood glucose levels
effectively. In our previous study, we reported that when
expression of the nuclear receptor COUP-TFII was depleted in
pancreatic b-cells, adult RIP
cre/- COUP-TFII
fl/wt mice were
glucose intolerant due to impaired glucose-stimulated insulin
secretion but b-cell mass at 14 weeks of age was unaffected [3].
Here we found that COUP-TFII is a novel positive regulator of b-
cell mass during the neonatal period in mice.
In this study, we demonstrate the physiological and molecular
consequences of homozygous COUP-TFII ablation selectively in
pancreas using the pdx-1 promoter controlling Cre recombinase
expression. We show that adult mice developed glucose intoler-
ance due to a reduction in b-cell number at birth. The total
number of glucagon- and insulin-expressing cells were similar in
mutant mice and control littermates from E12.5 to E14.5
suggesting that COUP-TFII is not involved in the early
development of endocrine cells. However, the reduction of the
number of small clusters of insulin containing cells within the
ductal epithelium at P5 together with the reduced number of b-
cells at P1 and further reduction at 3 weeks suggests decreased
neogenesis in the neonatal period. In addition, our results in vitro
show that COUP-TFII expression maintained b-cell survival.
Although we were unable to measure b-cell apoptosis in vivo due to
very low numbers of cells as found previously [35], we cannot
totally exclude the possibility that it contributes to b-cell reduction
in COUP-TFII knockout mice.
Our molecular studies in islets isolated from 6-week-old
pdx1
CRE/- COUP-TFII
Fl/Fl and in cultured INS-1 cells with loss
and gain of COUP-TFII function provide the first evidence that
this nuclear receptor participates in the Wnt/b-catenin/TCF7L2
dependent transcription signaling pathway in pancreatic b-cells.
Figure 3. Five-day-old pdx1
CRE/-, COUP-TFII
Fl/Fl mice have reduction of b-cell neogenesis and COUP-TFII knockdown increases 832/
13 INS-1 b-cells apoptosis. In pancreatic sections of 5-day-old mice (A) b-cell proliferation was assessed by double staining insulin/Ki67 (B) b-cell
neogenesis activation was evaluated through quantification of duct-associated insulin+ b-cells per unit of total tissue area. 832/13 INS-1 b-cells were
electroporated with scrambled or specific COUP-TFII siRNA and cultured in INS-1 medium for 24 h or 48 h. (C) Relative COUP-TFII mRNA levels
determined by RT-qPCR at 48 h. (D) Effect of COUP-TFII siRNA on cell viability analyzed by MTT assay (n=5 electroporations). (E) Effect of COUP-TFII
siRNA on b-cell proliferation. 832/13 INS-1 b-cells were cultured in INS-1 medium for 48 h and stained with BrdU. Cells were analyzed by flow
cytometry (n=4 electroprations). (F) Effect of COUP-TFII siRNA on b-cells apoptosis and comparison of the apoptotic rate with cell treated with a rat
cytokine mix containing 25 ng/ml TNF-a, 10 ng/ml IL-1b and 10 ng/ml INF-c during 24 h. 832/13 INS-1 b-cells were electroporated with scrambled or
COUP-TFII siRNA and 48 h later they were stained with DiOC6(3) and analyzed by flow cytometry (n=4 electroporations). * Significant difference
between values linked by brackets at P,0.03.
doi:10.1371/journal.pone.0030847.g003
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30847Figure 4. COUP-TFII regulates b-catenin signaling target genes in mouse islets and a b-cell line. (A) 832/13 INS-1 b-cells were
electroporated with scrambled (control) or COUP-TFII specific siRNA and cultured for 48 h. Levels of cyclin D1, c-myc, glutamine synthase, axin 2, and
b-catenin mRNA were determined by RT-qPCR. Effects on Wnt/b-catenin signaling were assessed by the luciferase activity of a TOP/FOP-flash
reporter. Results are means 6 SEM of data from between 3 and 12 (mRNA levels) independent electroporation experiments. Significant differences
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luciferase reporter gene that is specifically triggered by Wnt
signaling. We also observed that COUP-TFII increases b-catenin
gene expression, a central component of the canonical Wnt-
signaling pathway and consequently up-regulates some of the
target genes in b-cells. Whether or not the effect on b-catenin
transcription is mediated by direct COUP-TFII binding or by an
indirect action through other binding partners is not yet known.
Both mechanisms have been shown to be relevant to COUP-TFII
action in other cell types [36]. For example, mouse IGF-1 and
neuropilin-2 genes are positive direct targets of COUP-TFII
[37,38] and COUP-TFII binds to its promoter to negatively
control its expression in pancreatic b-cells [4]. During the neonatal
period, active Wnt/b-catenin-signaling is involved in the regula-
tion of pancreatic b-cell number in normal and stressed rats
mainly through proliferation and neogenesis [7]. In parallel
TCF7L2 depletion in islets results in increased b-cell apoptosis and
decreased b-cell proliferation [34].
Several hormones and growth factors activate the canonical
Wnt signaling pathway [16,11]. One such factor is GLP-1, which
is a gut-derived incretin hormone [39]. GLP-1 induces multiple
signaling pathways intrinsic to b-cell function [40,41,42]. GLP-1
protects pancreatic b-cells from apoptosis [20,19] and promotes b-
cell neogenesis in many rodent model systems and human
pancreatic ducts [43]. In unstressed rodents, an exogenous GLP-
1R agonist stimulates islet neogenesis [44] and restores a
functional pancreatic b-cell mass in the newborn Goto-Kakizaki
prediabetic rat [23]. A functional link between Wnt/b-catenin
signaling and GLP-1 signaling has been established where GLP-1
boosts pancreatic b-cell division by activating TCF7L2-dependent
Wnt signaling [17]. In human islets functional GLP1 signaling
requires TCF7L2 [45]. Our results suggest that COUP-TFII acts
as a molecular link between these two pathways. Our results
demonstrate that COUP-TFII is required for GLP-1 activation of
the b-catenin/TCF7L2 signaling pathway and its downstream
target cyclin D in isolated islets and in INS-1 b-cells. In parallel,
two target genes of GLP-1 signaling, GLP-1R and pdx-1
expression were significantly lower in mutant islets compared to
control islets and COUP-TFII expression was lowered by
depletion of the Wnt signaling-associated transcription factor
TCF7L2 in human islets and rat b-cells. Altogether, these
observations suggest a complex interplay between several
components of the GLP-1 signal transduction pathway and we
propose that COUP-TFII is possibly a link between TCF7L2 and
GLP-1R expression (Figure 8).
In other tissues, COUP-TFII is involved in apoptosis,
proliferation and differentiation [37,38,46,47]. Our results suggest
that COUP-TFII is a critical transcription factor for the expansion
of b-cells during early neonatal life and COUP-TFII might
participate in determining b-cell survival. Questions as to the
relative contribution of b-cell proliferation versus islet neogenesis
to b-cell mass expansion and which progenitor cells which are
capable of generating endocrine cells during neonatal are highly
controversial. There is evidence that GLP-1 can stimulate
differentiation of b-cell precursors [48,43] and prevent apoptosis
[18,19,20]. We also observed expression of COUP-TFII in ductal
cells at E18.5 (Figure S5) and at least a subset of ductal cells can
still differentiate into endocrine cells in late development and the
early post-natal period P1 [29,30].
In conclusion, transcriptional control by COUP-TFII defines a
novel pathway linking physiological insulinotropic signaling to
mechanisms determining b-cell number in the pancreas. While
there are many drugs already available for the treatment of
T2DM, over two-thirds of people with the disease continue to
have suboptimal glucose control, and incretin therapies offer
benefits matched by no other T2DM treatment currently
available. We now expect to learn from studies of new transgenic
mice over-expressing COUP-TFII combined or not with GLP-1
analog treatment whether COUP-TFII will reduce and/or reverse
the development of diabetes.
Methods
Mouse genetics and genotyping
The derivation of the pdx1
CRE/-COUP-TFII
Fl/Fl mouse line
has been previously reported [3] except for the fact that the Cre
recombinase in this study is under the control of Pdx1 promoter
(Pdx1-Cre transgenic line provided by Dr Melton, [25]). COUP-
TFII PCR analysis was used to genotype mice using DNA isolated
from tail tips of newborns as already described [3]. Male or female
mutant mice were compared to COUP-TFII
Fl/Fl and pdx1
CRE/-
littermates of the same age and sex. Embryos were studied at
embryonic day (E) 12.5 and E14.5; newborns were studied at 1
day, 5 days and pups at 21 days after birth; adult mice were
studied at 20 weeks of age. Animals were housed in colony cages
with a 12-h light/12-h dark cycle in a temperature-controlled
environment and fed ad libitum with a standard laboratory chow
diet: composition 65% carbohydrate, 11% lipids and 24% proteins
(SAFE, France R03-10). All procedures were performed in
accordance with the principles and guidelines established by the
European Convention for the Protection of Laboratory Animals
under animal experimentation permit number 5820 from the
Ministre de l’enseignement supe ´rieur et de la recherche ´ (France)
and animal care facility agreement number A-75-14-02.
Immunostaining and quantification of b-cell and a-cell
mass in 21-day-old and adult mice
Pancreases were removed from sacrified animals and weighed.
Whole pancreases were Bouin fixed and paraffin embedded. Each
pancreatic block was serially sectioned (7 mm thickness) through-
out its length. Every 35 sections throughout the block, ten sections
were randomly chosen and immunostained for insulin or glucagon
using indirect peroxidase labeling. Sections were incubated for 1 h
with primary antibodies guinea pig anti-insulin serum (dilution
1:1000) or rabbit antiglucagon serum (dilution 1:600) from MP
Biomedicals, Orsay, France. Sections were incubated for 45 min
with peroxydase-conjugated rabbit anti-guinea pig IgG (dilution
1:50; Dako, Trappes, France) or goat anti-rabbit IgG (final
between COUP-TFII knockdown and control values are shown by asterisks at the P value indicated. *P,0.05; **P,0.03. (B) A representative
immunoblot of different experiments of 832/13 INS-1 b-cells that were electroporated with scrambled or COUP-TFII specific siRNA. 50 m g of total
protein extract was subjected to immunoblot analysis with antibodies against cyclin D1, CDK4 or b-actin. (C) RT-qPCR analysis of b-catenin and cyclin
D1 mRNA levels of 832/13 INS-1 cells infected with Ad-GFP or Ad-hCOUP-TFII at 2 or 5 PFU per cell as indicated [4] normalized to housekeeping gene
cyclophilin. Results are means 6 SEM of data from 3 independent infection experiments. *Significant difference between between COUP-TFII
overexpression and control values at P,0.05 (D) RT-qPCR analysis of b-catenin, cyclin D1, axin 2, pdx1 and proinsulin I-II mRNA from islets from 5-
week-old pdx1
CRE/-, COUP-TFII
Fl/Fl and pdx1
CRE/- COUP-TFII
Fl/Fl mice. Results are mean 6 SEM (error bars) for 5 animals per genotype. *P,0.05 for
pdx1
CRE/- COUP-TFII
Fl/Fl versus COUP-TFII
Fl/Fl and pdx1
CRE/- control mice.
doi:10.1371/journal.pone.0030847.g004
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e30847Figure 5. GLP-1 signaling enhances cyclin D1 gene expression via COUP-TFII and b-catenin expression. (A) GLP-1 and Exd4 stimulate
IGF1-R expression in the 832/13 INS-1 b-cells. Wild-type 832/13 INS-1 b-cells were cultured in INS-1 medium and stimulated for 6 h with (+) or without
(-) 100 nM GLP-1 or 10 nM Exd4 and IGF1-R mRNA levels were analyzed by RT-qPCR and normalized to housekeeping gene cyclophilin. Numbers over
brackets indicate fold increase between Exd4 and GLP-1 treated samples and the control as indicated. Results are means 6 SEM of data from 5
independent electroporation experiments. Significant differences between values linked by brackets are shown by asterisks at P value indicated.
**P,0.03. ***P,0.001. (B) Absence of COUP-TFII abrogates Exd4 stimulated cyclin D1 expression in 832/13 INS-1 b-cells. 832/13 INS-1 b-cells were
electroporated with scrambled or specific COUP-TFII siRNA, infected or not infected with recombinant b-catenin adenovirus and stimulated with (+)
or without (-) 100 nM GLP-1 or 10 nM Exd4 for 6 h. Cyclin D1 mRNA levels was analysed by RT-qPCR. Numbers indicate fold-increase of cyclin D1
expression. Results are means 6 SEM of data from 5 independent electroporation experiments. ***Significant differences between values linked by
brackets at P,0.001. (C) In vivo crosstalk of GLP-1 and Wnt signaling pathways. RT-qPCR analysis of IGF-1R, cyclin D1 and axin 2 mRNA levels were
performed on mouse islets isolated from GipR
-/-; Glp-1-R
-/- transgenic mice normalized to housekeeping gene cyclophilin. Data are means 6 SEM for 5
animals of each genotype. *Significant difference between transgenic and control values at P,0.05.
doi:10.1371/journal.pone.0030847.g005
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tetra-hydrochloride (DAB) (kit DAB; Valbiotech, Compiegne,
France). Sections were mounted in Eukitt (Labonord).
For each section, the total surface area and area of b-cells
(insulin-positive) or a-cells (glucagon-positive) were estimated by
computer-assisted image analysis using an Olympus BH2
microscope connected via a color video camera to a personal
computer with Histolab 5.14 software (Microvision Instruments,
Evry, France). The relative volume of b-o ra-cells was determined
by stereological morphometric methods, calculating the ratio
between the area occupied by immunoreactive cells and that
occupied by all pancreatic cells. Total b-cell or a-cell mass per
pancreas was calculated by multiplying this ratio by the whole
pancreas mass.
COUP-TFII expression in adult pancreatic sections from
COUP-TFII
Fl/Fl and pdx1
CRE/-COUP-TFII
Fl/Fl was assessed as
previously described [4].
Estimation of endocrine cell number and mass in E12.5,
E14.5 and newborn mice
Each pancreatic block was serially sectioned (8 mm thickness)
throughout its length. From each pancreas from newborns, 1
section was quantified every 10 sections, giving a total of about 20
sections. For each E12.5 pancreas, 1 section was quantified every 3
sections, giving a total of about 12 sections. For each E14.5
pancreas, 1 section was quantified every 5 sections giving a total of
about 12 sections. Sections were incubated overnight with primary
antibodies guinea pig anti-insulin serum (dilution 1:100, Dako) and
rabbit anti-glucagon serum (dilution 1:600, Linco). Sections were
then incubated for 1 h with Alexa Fluor 488-conjugated anti-
rabbit IgG (final dilution 1:200; Molecular Probes) and Alexa
Fluor 555-conjugated goat anti-guinea pig IgG (final dilution
1:1000; Molecular probes). Slides were counterstained with DAPI
(diamidino-2-phenylindole). Sections were mounted in PBS-
glycerol (1:1, v/v). E12.5 and E14.5 adjacent sections were stained
overnight with rabbit anti-Pdx1 (1:60,000, courtesy of Chris
Wright). Then sections were incubated for 1 h with Alexa Fluor
488-conjugated anti-rabbit IgG (final dilution 1:200; Molecular
Probes). The total numbers of b-cells or a-cells at E12.5 and E14.5
were counted using a Leica DM5500 microscope connected via a
color video camera to a personal computer although E12.5
insulin-positive cells were not numerous enough to be counted
reliably. Pdx1-positive areas were quantified on mosaic images
taken with the same microscope with a 20X objective using
ImageJ sofware. Areas with signal intensity above a defined
threshold were counted. To quantify the DAPI area, mosaic
images were captured with the same microscope/camera/
computer set-up with a 106objective. Positive areas were defined
with the lasso function and measured using Image J sofware.
Histological studies
Five-day-old pancreases were removed from sacrificed animals
(4 mice per group) and weighed. Whole pancreases were fixed
12 h in 4% paraformaldehyde and paraffin embedded. Each
paraffin block containing the pancreases was serially sectioned
throughout its length.
b-cell proliferation
Ten sections were randomly chosen and were double stained for
insulin and Ki67 (NCL-Ki67P, Leica). To estimate the prolifer-
ation rate, b-cells and Ki67-positive b-cells were counted using an
Olympus BX40 microscope. At least 2,000 cells were counted per
pancreas.
b-cell apoptosis
Apoptotic cells were detected by terminal deoxynucleotidyl
transferase dUTP-mediated nick-end labeling (TUNEL; Millipore)
assay as previously described [7].
b-cell neoformation from ductal precursors
To obtain an estimation of b-cell neogenesis activation, we
quantified single b-cells and clusters of b-cells in the duct
epithelium as previously described [22]. Values for insulin+/b-
cells are related to total pancreatic section area and cells were
determined per mm
2 of pancreatic tissue at P5.
Intraperitoneal glucose tolerance test and insulin
assay. Intraperitoneal glucose tolerance tests were performed
on mice that had been fasted for 14 h. Animals were injected
Figure 6. COUP-TFII controls GLP-1R expression in islet. RT-qPCR analysis of IGF-1R and GLP-1R mRNA from islets from 5-week-old pdx1
CRE/-,
COUP-TFII
Fl/Fl and pdx1
CRE/- COUP-TFII
Fl/Fl mice normalized to housekeeping gene cyclophilin. Results are mean 6 SEM (error bars) for 5 animals per
genotype. *P,0.05 for pdx1
CRE/- COUP-TFII
Fl/Fl versus COUP-TFII
Fl/Fl and pdx1
CRE/- control mice.
doi:10.1371/journal.pone.0030847.g006
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withdrawn from the tail vein. Blood glucose was measured
immediately before and 20, 40, 60, and 120 min after glucose
injection using the Accu-Check II glucometer (Roche Diagnostic).
Blood samples taken at the same times were immediately
centrifuged at 4uC, and the plasma was stored at -80uC until
assayed. Plasma insulin was measured with a radioimmunoassay
kit (Diasorin, Antony, France).
Cell culture. The rat insulinoma 832/13 INS-1 cell line was
used between passages 7 and 25 [49]. Cells were cultured at 5%
CO2–95% airat37uC inRPMI640mediumcontaining11 mMD-
glucose supplemented with 10% (v/v) heat-inactivated fetal bovine
serum, 100 U/ml penicillin-streptomycin, 10 mM HEPES, 1 mM
sodium pyruvate (Invitrogen), and 50 mM b-mercaptoethanol
(Invitrogen) (INS-1 medium). Cells in INS-1 medium were
stimulated with 10 nM Exd4 (Exenatide, Byetta) or 100 nM
GLP-1 (7-36) amide (Catalogue number 028-11, Phoenix) for
15 min or 6 h. Human islets were isolated from pancreases of three
healthy organ donors as described previously [50,51,52] cultured in
full CMRL medium (Invitrogen) [34] on extracellular matrix–
coated plates derived from bovine corneal endothelial cells
(Novamed Ltd., Jerusalem, Israel), allowing the cells to attach to
the dishes and spread for 24 h before transfection to preserve their
functional integrity [53,54].
Gene silencing with siRNA. COUP-TFII and TCF7L2
(SI03385851, Qiagen) depletion experiments in the 832/13 INS-1
cell line were performed as described previously [5]. Cells (1.2610
6)
were transfected with 68 and 50 pmol of COUP-TFII siRNA and
Figure 7. COUP-TFII expression is activated by TCF7L2 in b-cells. (A) Fixed healthy human islets were triple-stained for COUP-TFII in red, for
insulin in green and DAPI in blue. (B) 832/13 INS-1 b-cells were electroporated with scrambled (control) or specific TCF7L2 siRNA and cultured for
48 h. Relative TCF7L2, COUP-TFII and cyclin D1 mRNA levels were determined by RT-qPCR normalized to housekeeping gene cyclophilin. Results are
means 6 SEM of data from between 4 independent electroporation experiments. Significant differences between TCF7L2 knockdown and control
values are shown by asterisks at the P value indicated. *P,0.05.
doi:10.1371/journal.pone.0030847.g007
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electroporation using an Amaxa Nucleofector II device (solution T,
program T20; Amaxa Biosystems) and cultured during 48 h.
Isolated human islets were exposed to transfection Ca
2+-KRH
medium (4.74 mM KCl, 1.19 mM KH2PO4, 1.19 mM
MgCl26H2O, 119 mM NaCl, 2.54 mM CaCl2, 25 mM
NaHCO3, 10 mM HEPES). SiRNA-Lipofectamine 2000 com-
plexes were prepared according to the manufacturer’s instructions
(Lipofectamine2000; invitrogen) using 50 nM siRNA to TCF7L2
(RNAs of 21 nucleotides, designed to target human TCF7L2;
Stealth Select
TM RNAi, invitrogen) and scrambled siRNA
(Ambion, Austin, TE) as described before [55]. After overnight
incubation, the transfection medium was aspirated and replaced
by fresh culture medium. Islets were fixed 72 h later in Bouins
fixative embedded in paraffin and islet sections were prepared
after dehydration. Sections were deparaffinized, rehydrated and
incubated overnight at 4uC with mouse anti-COUP-TFII (Perseus
Proteomics H7147-00) and guinea pig anti-insulin antibodies
(Dako, Carpinteria, CA), followed by detection using cy3 and
fluorescein-conjugated antibodies (Jackson) and embedded in
Vectashield mounting medium (Vector Laboratories, Burlingame,
CA), to visualize all cells by 4,6-diamidino-2-phenylindole (DAPI)
staining. Fluorescence was analyzed using a Nikon MEA53200
(Nikon GmbH Duesseldorf, Germany) microscope and images
were acquired using Openlab (Improvision Inc, Waltham, MA
02451,USA) or NIS-Elements software (Nikon). Western blotting
was performed to check the level of downregulation of TCF7L2
and resulted in 4-fold downregulation compared to siScr-treated
control as shown before [45].
Cell viability assay. After 48 h of COUP-TFII inactivation
by siRNA, cell viability was assayed using the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay
following the Cellitoter 96 assay (Promega G4000) procedure.
Flow cytometry measurements. Cultured 832/13 INS-1
cells were pretreated with scrambled or COUP-TFII-specific
siRNA for 48 h. Proliferation of b-cells was evaluated by
measuring 5-bromo-29-deoxyuridine (BrdU) incorporation using
APC BrdU Flowkit (catalogue number 552598, BD Pharmingen).
Cells were incubated with BrdU (10 mM) for 1 h at 37uC. Then
cells were washed, trypsinized and fixed with cytofix/cytosperm
buffer. Development of BrdU staining was done following the kit
procedure. DNA was stained with 7-aminoactinomycin D (7-
AAD) and cells were analyzed by using FACS Calibur4C (Becton
Dickinson) with the FL-1 channel (band pass 530 6 30 nm) for
BrdU and the FL-3 channel (long pass 670 nm) for 7-ADD.
Changes in mitochondrial membrane potential (Dym) were
evaluated by labeling cells with DiOC6(3). Cells were incubated
for 20 min at room temperature with 10 nM DiOC6(3) and
labeled with propidium iodide (PI, 1 mg/ml). Cell fluorescence
was measured after suitable spectral compensation in the FL-1
channel for DiOC6(3) and the FL-3 channel for PI. To induce
apoptosis, cells were treated with a rat cytokine mix containing
25 ng/ml TNF-a (catalogue number 400-14, Peprotech), 10 ng/
ml IL-1b (catalogue number 400-01, Peprotech), and 10 ng/ml
INF-c (catalogue number 400-20, Peprotech) during 24 h.
Plasmid, transfection and reporter gene assay. The T-
cell factor (TCF)-responsive TOPflash vector (Addgene) expressing
luciferase driven by multiple TCF-responsive elements was used to
evaluate the activity of b-catenin. Transfection and reporter gene
assays were done as previously described [4].
Adenovirus infection. Recombinant adenoviruses expressing
GFP alone (Ad-GFP) or with human COUP-TFII (Ad-hCOUP-
TFII) were generated and used as described previously [4].
Recombinant adenovirus expressing GFP alone (Ad-GFP) or with
human wild-type b-catenin (Ad-b catenin) were generously
provided by Dr CJ Li [56]. After COUP-TFII gene silencing, b-
cells were infected with a multiplicity of infection of 20 in 500 m l
INS-1 medium for 2 h at 37uC and then cultured for 24 h before
stimulation with or without Exd4 for 6 h.
Pancreatic islet isolation. Pancreatic islets of 5 week-old-
pdx1
CRE/-, COUP-TFII
Fl/Fl and COUP-TFII
Fl/Fl pdx1
CRE/-
mice were isolated as previously described [4]. Total RNA was
extracted from hand-picked islets using the Absolutely RNA
microprep kit according to the instructions provided by the
manufacturer (Stratagen).
Microarray expression profiling and data analysis. We
determined the RNA profile of COUP-TFII knockdown b-cells
(832/13 INS-1 cells transfected with COUP-TFII specific siRNA)
with respect to control cells (832/13 INS-1 cells transfected with
scrambled siRNA) using Affymetrix expression analysis technical
manual 701025Rev.5 (Affymetrix, Santa Clara, California, USA).
Briefly, 1 mg of total cellular mRNA was reverse transcribed
into cDNA (SuperScript Choice System Invitrogen, Carlsbad, CA)
using oligo-dT primers and a T7 RNA polymerase promoter
site. The cDNA was in vitro transcribed and biotin-labeled for
microarray analysis using the Affymetrix IVT labeling kit. The
concentration of labelled cRNA was measured using a NanoDrop
ND-1000 spectrophotometer. Labeled cRNA was fragmented in a
fragmentation buffer for 35 min at 94uC. The quality of labeled
and fragmented cRNA was analyzed using the Agilent bioanalyzer
2100 [57]. Fragmented cRNA was hybridized to the rat 230 2.0
array (Affymetrix) during 16h at 45uC. Arrays were washed and
Figure 8. Proposed scheme of how COUP-TFII increases b-cell
numbers through GLP-1 signaling cascade during the neonatal
period in mice. Positive regulation (arrows) of indirect COUP-TFII
target’s genes in pancreatic b-cells.
doi:10.1371/journal.pone.0030847.g008
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the Affymetrix 3000 GeneScanner.
Intensity of microarray probe signals were background-subtracted
and normalized using reference probes. Individual probe values
from 3 chips per treatment were used to calculate mean fold change.
Log2-transformed values were employed for statistical analysis
(Student’s t test, Figure S3). Significant changes in gene expression
(where P#0.05) were filtered, annotated using NetAffx Data
Analyses Center v31 [58]; http://www.affymetrix.com/analysis/
index.affx) and analyzed using Ingenuity Pathway Analysis (In-
genuityH Systems; www.ingenuity.com), Gene Set Analysis Toolkit
V2(GSAT;[59]and David BioinformaticsResources6.7(DavidBR,
[60]. Results are available in the GEO database, accession number
GSE30526 and are shown in Figure S2 and Figure S3.
Isolation of total mRNA and transcript detection by RT-
qPCR. Total RNA was extracted and purified from cultured
cells using the RNA-Plus reagent according to the manufacturer’s
institutions (Q-BIOgene). Reverse transcription was done with
2 mg of total RNA using Superscript II reverse transcriptase
(Invitrogen) according to the manufacturer’s protocol. RT-qPCR
was performed with 6.25 ng of reverse-transcribed total RNA,
10 mM of each primer (Eurogentec), and 2 mM MgCl2 in 1x
LightCycler DNA Master SYBR Green I mix using a LightCycler
device (Roche). All samples were normalized to the threshold cycle
value for cyclophilin mRNA, chosen as an invariant control.
Forward and reverse primers used for the specific amplification of
cDNA fragments were described by [5] or designed to hybridize to
rat and/or mouse transcripts. Primer sequences will be provided
on request.
Islet cDNA was prepared from GipR
-/-; Glp-1-R
-/- transgenic
mice and control littermates [20] and gene expression analysis was
performed by RT-qPCR as above.
Immunoblotting. Total and cytosolic 832/13 INS-1 proteins
were prepared as described in reference [4]. Protein extracts were
sonicated and 10 to 50 mg was subjected to SDS-PAGE followed
by immunoblotting with specific antibodies for: cyclin D1 at
1:1,000 dilution (Neomarkers clone sp4 RM-9104/monoclonal
rabbit anti-human) ; CDK4 at 1:1,000 dilution (catalogue number
6315, Abcam); b-actin at 1:2,000 dilution (catalogue number
A2066, Sigma) or unphosphorylated (active) b-catenin at dilution
1:1,000 dilution (catalogue number 05-665, Millipore).
Immunoreactive bands were revealed using ECL SuperSignal
West Pico chemiluminescent reagents (Pierce). Autoradiograms
were scanned using Chemi Genius 2 Bioimaging System and
quantified using Image J software.
Statistical analysis. Quantitative results are expressed as
means 6 standard errors of the mean (SEM). Statistical analyses
were carried out using the Mann-Whitney test, a nonparametric
statistical program appropriate when the sample number is less
than 10. Null hypotheses were rejected at P values of .0.05. All
experiments were performed at least three times.
Supporting Information
Figure S1 Absence of COUP-TFII in mouse pancreatic b-
cells does not modify a-cell number.
(TIF)
Figure S2 Categorization of COUP-TFII modulated
genes in 832/13 INS-1 cells by biological process,
molecular function and cellular component.
(PDF)
Figure S3 Analysis of broad gene ontology terms (GO
Slim) based on GSAT v2.
(PDF)
Figure S4 Exd4 stabilizes cytosolic endogenous and
over-expressed b-catenin in 832/13 INS-1 b-cells and
Exd4 induces cyclin D1 mRNA levels via b-catenin
signaling pathway.
(TIF)
Figure S5 COUP-TFII expression in mouse ductal
epithelium and in periductal mesenchyme at 18.5.
(TIF)
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